Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Forbion Capital Partners

Status
ACTIVE
Global HQ
Massachusetts, United States
Countries of investment
  • Netherlands
Investment stages
  • Seed
  • Series A
Industries
  • Manufacturing
  • Consumer Health
  • Pharmaceuticals
  • Diagnostics
  • Biotechnology
  • Digital Health
About
Forbion Capital Partners is a prominent Netherlands-based venture capital firm dedicated to transforming the landscape of medicine through strategic investments in life sciences companies focused on drug development. With a strong emphasis on collaboration, Forbion partners closely with entrepreneurs and innovators to accelerate the growth of groundbreaking therapies and technologies. Leveraging extensive industry expertise and a robust network, Forbion aims to drive advancements that significantly impact patient care and improve health outcomes worldwide.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

Forbion focuses on fostering healthcare innovation by building life sciences companies through close collaboration with scientists, entrepreneurs, and academic institutions.
Lead investor
Co Invest
Number of exits
Preferred contact method

Forbion Capital Partners Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp